NCT07287098
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07287098
Title A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer (PreEMBER)
Acronym PreEMBER
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | DEU | BEL


No variant requirements are available.